生物技术公司Lineage Cell Therapeutics Inc(股票代码:LCTX)近日宣布,将于2026年5月12日发布2026年第一季度财务业绩报告。此次公告将全面披露公司在该季度的经营表现和财务数据。
同时,管理层将举行业务更新会议,深入阐述公司最新研发进展、战略规划及未来展望。投资者可通过指定渠道参与实时交流,获取第一手企业动态。
生物技术公司Lineage Cell Therapeutics Inc(股票代码:LCTX)近日宣布,将于2026年5月12日发布2026年第一季度财务业绩报告。此次公告将全面披露公司在该季度的经营表现和财务数据。
同时,管理层将举行业务更新会议,深入阐述公司最新研发进展、战略规划及未来展望。投资者可通过指定渠道参与实时交流,获取第一手企业动态。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.